Completion pneumonectomy: Current indications, complications, and results Toshio Fujimoto, MD, George Zaboura, MD, Sylvia Fechner, MD, Ludger Hillejan,

Slides:

Advertisements

Similar presentations

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Advertisements

Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: Activation of the mitochondria-dependent death-signaling.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

A.Marc Gillinov, MD, Gosta Pettersson, MD, Thomas W. Rice, MD

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Lung cancer screening: No more excuses

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

Ground glass opacity of the lung: The veil that needs lifting

Survival after resection of synchronous non–small cell lung cancer

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Recurrent thoracic outlet syndrome

An economic evaluation of lung transplantation

The lord of the rings Antonio Miceli, MD, PhD

Historical perspectives of The American Association for Thoracic Surgery: George P. Muller, MD, ScD ( ) Richard N. Edie, MD The Journal of Thoracic.

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Conduit conundrum: If not two, why three?

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

A.Marc Gillinov, MD, Gosta Pettersson, MD, Thomas W. Rice, MD

Yang Zhang, MD, Haiquan Chen, MD, PhD

Subclavian artery involvement by apical chest tumors: A specific indication for the transmanubrial approach Lorenzo Spaggiari, MD, PhD, Ugo Pastorino,

Support Your Specialty

It's not “just a shunt” but sometimes it should be…

Bartley P. Griffith, MD, FACS, FRCS

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Get it right the first time

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Mark K. Ferguson, MD, Amy E. Durkin, MS, PA-C

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Living without lungs? Bilateral pneumonectomy and dual circulatory support: A step forward in the search for a total artificial lung Christian A. Bermudez,

Is parameter T staging influenced by tumor behavior?

Marc Licker, MD, John Diaper, RA

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

Internal validation of risk models in lung resection surgery: Bootstrap versus training- and-test sampling Alessandro Brunelli, MD, Gaetano Rocco, MD

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

We are the company we keep: The importance of the tumor microenvironment Sai Yendamuri, MD, FACS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Who is your plastic surgeon

Is there a role for pneumonectomy in pulmonary metastases?1

O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tai Ji: The law of inflammatory response

Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed Melanie P. Subramanian, MD, Varun Puri, MD, MSCI

The future of cardiac surgery training: A survival guide

Homograft valve repair for recurrent prosthetic valve endocarditis

Neal S Goldstein, MD The Annals of Thoracic Surgery

Building a clinical program in a single institution

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Aritoshi Hattori, MD, Kenji Suzuki, MD

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

European Society of Thoracic Surgeons preoperative mediastinal staging guidelines: From face validity to external validity Alessandro Brunelli, MD The.

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Edward Y. Chan, MD, Michael J. Reardon, MD

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

Completion pneumonectomy: Current indications, complications, and results Toshio Fujimoto, MD, George Zaboura, MD, Sylvia Fechner, MD, Ludger Hillejan, MD, Thomas Schröder, MD, Alessandro Marra, MD, Thomas Krbek, MD, Marc Hinterthaner, MD, Dieter Greschuchna, MD, Georgios Stamatis, MD The Journal of Thoracic and Cardiovascular Surgery Volume 121, Issue 3, Pages 484-490 (March 2001) DOI: 10.1067/mtc.2001.112471 Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Analysis of survival related to indications for completion pneumonectomy. The Journal of Thoracic and Cardiovascular Surgery 2001 121, 484-490DOI: (10.1067/mtc.2001.112471) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Analysis of survival in the group with malignant indications. LR, Local recurrence; IR, incomplete resection; SP, second primary lung cancer; MT, metastatic lung tumor. The Journal of Thoracic and Cardiovascular Surgery 2001 121, 484-490DOI: (10.1067/mtc.2001.112471) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions